These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 23463621)

  • 1. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists.
    Brandi J; Dando I; Palmieri M; Donadelli M; Cecconi D
    Electrophoresis; 2013 May; 34(9-10):1359-68. PubMed ID: 23463621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.
    Dando I; Donadelli M; Costanzo C; Dalla Pozza E; D'Alessandro A; Zolla L; Palmieri M
    Cell Death Dis; 2013 Jun; 4(6):e664. PubMed ID: 23764845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
    Small-Howard AL; Shimoda LM; Adra CN; Turner H
    Biochem J; 2005 Jun; 388(Pt 2):465-73. PubMed ID: 15669919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.
    Dhopeshwarkar A; Murataeva N; Makriyannis A; Straiker A; Mackie K
    J Pharmacol Exp Ther; 2017 Feb; 360(2):300-311. PubMed ID: 27927913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
    Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.
    Harvey BS; Ohlsson KS; Mååg JL; Musgrave IF; Smid SD
    Neurotoxicology; 2012 Jan; 33(1):138-46. PubMed ID: 22233683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.
    Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
    J Immunotoxicol; 2009 Dec; 6(4):249-56. PubMed ID: 19908944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes.
    De Gottardi A; Spahr L; Ravier-Dall'Antonia F; Hadengue A
    Liver Int; 2010 Nov; 30(10):1482-9. PubMed ID: 20602678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
    Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
    Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
    Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
    Govaerts SJ; Hermans E; Lambert DM
    Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists.
    Saari R; Törmä JC; Nevalainen T
    Bioorg Med Chem; 2011 Jan; 19(2):939-50. PubMed ID: 21215643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
    Chu GH; Saeui CT; Worm K; Weaver DG; Goodman AJ; Broadrup RL; Cassel JA; DeHaven RN; LaBuda CJ; Koblish M; Brogdon B; Smith S; Le Bourdonnec B; Dolle RE
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5931-5. PubMed ID: 19736007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
    Börner C; Höllt V; Sebald W; Kraus J
    J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts.
    Lépicier P; Lagneux C; Sirois MG; Lamontagne D
    Life Sci; 2007 Oct; 81(17-18):1373-80. PubMed ID: 17931662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists.
    Yrjölä S; Kalliokoski T; Laitinen T; Poso A; Parkkari T; Nevalainen T
    Eur J Pharm Sci; 2013 Jan; 48(1-2):9-20. PubMed ID: 23131798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2.
    Arévalo-Martín A; García-Ovejero D; Rubio-Araiz A; Gómez O; Molina-Holgado F; Molina-Holgado E
    Eur J Neurosci; 2007 Sep; 26(6):1548-59. PubMed ID: 17880390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.